Important Role for Endothelins in Acute Hepatic Ischemia/Reperfusion Injury

REFERENCES

• Post S, Messmer K. Die Rolle des Reperfusionsschadens. Chirurg. 1996;67:318–323.
   Google Scholar
• Suzuki S, Toledo-Pereyra LH, Rodriguez FJ. Role of neu- trophils during the frst 24 hours after liver ischemia and reperfusion injury. Transplant Proc. 1994;26:3695 – 3700.
   Google Scholar
• Clavien PA, Harvey PRC, Strasberg SM. Preservation and reperfusion injuries in liver allografts. Transplantation. 1992;53:957–978.
   PubMed Web of Science ®Google Scholar
• Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascu- lar endothelial cells. Nature. 1988;332:411 –415.
   Google Scholar
• Kawamura E, Yamanaka N, Okamoto E, Tomoda F, Furukawa K. Response of plasma and tissue endothelin- 1 to liver ischemia and its implication in ischemia- reperfusion injury. Hepatology. 1995;21:1138–1143.
   PubMed Web of Science ®Google Scholar
• Stephenson K, Gandhi CR, Olson MS. Biological actions of endothelin. Vit Horm. 1994;48:157 –198.
   Google Scholar
• McMillen MA, Sumpio BE. Endothelins: Polyfunctional cy- tokines. J Am Coll Surg. 1995;180:621–637.
   PubMed Web of Science ®Google Scholar
• Kurihara H, Yoshizumi M, Sugiyama T, Yamaoki K, Nagai R, Takaku F, Satoh H, Yanagisawa M, Masaki T, Yazai Y. The possible role of endothelin in the patho- genesis of coronary vasospasm. J Cardiovasc Pharmacol. 1989;13(Supp l 5): S132–S137.
   Google Scholar
• Brochu E, Lacasse S, Moreau C, Lebel M, Kingma I, Grose JH, Lariviere R. Endothelin ET(A) receptor blockade pre- vents the progression of renal failure and hypertension in uraemic rats. Nephrol Dial Transplant. 1999;14:1881 – 1888.
   Google Scholar
• Uhlmann D. Verringerung des hepatischen Ischamie/ Reperfusionsschadens durch kontrollierte Vasoregula- tion der Lebermikrozirkulation. Nova Acta Leopoldina. 1998;Supp l 15:73–90.
   Google Scholar
• Clozel M, Breu V, Gray GA, Kalina B, Lo¨ fler BM, Burri K, Cassal JM, Hirth G, Mu¨ ller M, Neidhart W, Ramuz H. Phar- macological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Pharmacol Exp Ther. 1994;270:228 –235.
   Google Scholar
• Breu V, Lo¨ fler BM, Clozel M. In vitro characterization of Ro 46-2005, a novel synthetic non-peptide endothelin antag- onist of ETA and ETB receptors. FEBS Lett. 1993;334:210 – 214.
   Google Scholar
• Uhlmann S, Uhlmann D, Spiegel HU. Evaluation of hep- atic microcirculation by in vivo microscopy. J Invest Surg. 1999;12:179–193.
   PubMedGoogle Scholar
• Menger MD, Marzi I, Messmer K. In vivo luorescence mi- croscopy for quantitative analysis of the hepatic microcir- culation in hamsters and rats. Eur Surg Res. 1991;23:158 – 169.
   Google Scholar
• Marzi I, Knee J, Buhren V, Menger M, Trenz O. Reduction by superoxide dismutase of leukocyte-endothelia l adher- ence after liver transplantation. Surgery. 1992;111:90 – 97.
   Google Scholar
• Post S, Palma P, Rentsch M, Gonzalez AP, Menger MD. Differential impact of Carolina rinse and Univer- sity of Wisconsin solution on microcirculation, leuko- cyte adhesion, Kupffer cell activity and biliary excretion after liver transplantation. Hepatology. 1993;18:1490 – 1497.
   Google Scholar
• Spiegel HU, Hauss J, Scho¨ nleben K, Bu¨ nte H. Theory and methods of local tissue-pO2 monitoring in experimental angiology. Angiology. 1987;38:1–12.
   Google Scholar
• Lo¨ fler BM, Maire JP. Radioimmunologica l determination of endothelin peptides in human plasma: A methodolog- ical approach. Endothelium. 1994;1:273–286.
   Google Scholar
• Theodorsen L. Dry reagent technology. Kodak Ektachem 700 XR in clinical enzymology. Scand J Clin Lab Invest. 1993;215:101 –111.
   Google Scholar
• Almond NE, Wheatley AM. Measurement of hepatic per- fusion in rats by laser Doppler lowmetry. Am J Physiol. 1992;262:G203–G209.
   Google Scholar
• Lu¨ scher TF, Yang Z, Diederich D, Bu¨ hler FR. Endothelium- derived vasoactive substances: Potential role in hyperten- sion, atherosclerosis, and vascular occlusion. J Cardiovasc Pharmacol. 1989;14(Supp l 6): S63–S69.
   Google Scholar
• Rockey D. The cellular pathogenesi s of portal hyperten- sion: Stellate cell contractility, endothelin, and nitric oxide. Hepatology. 1997;25:2–5.
   Google Scholar
• Epstein M, Goligorsky MS. Endothelin and nitric oxide in hepatorena l syndrome: A balance reset. J Nephrol. 1997;10:120–135.
   PubMed Web of Science ®Google Scholar
• Scommotau S, Uhlmann D, Lofler BM, Breu V, Spiegel HU. Involvement of endothelin/nitric oxide balance in hepatic ischemia/reperfusion injury. Langenbecks Arch Surg. 1999;384:65 –70.
   Google Scholar
• Rubanyi GM, Polokoff MA. Endothelins: Molecular biol- ogy, biochemistry, pharmacology, physiology, and patho- physiology. Pharmacol Rev. 1994;46:325 –415.
   Google Scholar
• Lerman A, Click RL, Narr BJ, Wiesner RH, Krom RAF, Textor SC, Burnett JC. Elevation of plasma endothelin associated with systemic hypertension in humans following ortho- topic liver transplantation. Transplantation. 1991;51:646 – 650.
   Google Scholar
• Textor SC, Wilson DJ, Lerman A, Romero JC, Burnett JC, Wiesner R, Dickinson ER, Krom RAF. Renal hemodynamics, urinary eicosanoids, and endothelin after liver transplan- tation. Transplantation. 1992;54:74–80.
   PubMed Web of Science ®Google Scholar
• Goto M, Takei Y, Kawano S, Nagano K, Tsuji S, Masuda E, Nishimura Y, Okumura S, Kashiwagi T, Fusamoto H, Kamada T. Endothelin- 1 is involved in the pathogenesi s of ischemia/reperfusion liver injury by hepatic microcircu- latory disturbances. Hepatology. 1994;19:675–681.
   PubMed Web of Science ®Google Scholar
• Farre´ AL, Riesco A, Espinosa G, Digiuni E, Cernadas MR, Alvarez V, Monto´ n M, Rivas F, Gallego MJ, Egido J, Casado S, Caramelo C. Effect of endothelin-1 on neutrophil adhe- sion to endothelial cells and perfused heart. Circulation. 1993;88:1166 –1171.
   Google Scholar
• Ota T, Hirai R, Urakami A, Soga H, Nawa S, Shimizu N. Endothelin- 1 levels in portal venous blood in rela- tion to hepatic tissue microcirculation disturbances and hepatic cell injury after ischemia/reperfusion. Jpn J Surg. 1997;27:313 –320.
   Google Scholar
• Battistini B, Forget MA, Laight D. Potential roles of en- dothelin in systemic inlammatory response syndrome with a particular relationship to cytokines. Shock. 1996;5:167–183.
   PubMedGoogle Scholar
• Sugiura M, Inagami T, Kon V. Endotoxin stimulates en- dothelin release in vivo and in vitro as determined by radioimmunoassay. Biochem Biophys Res Commun. 1989;161:1220 –1226.
   Google Scholar
• Wanner GA, Muller PE, Ertel W, Bauer M, Menger MD, Messmer K. Differential effect of anti-TNF-alpha anti- body on proinlammatory cytokine release by Kupffer cells following liver ischemia and reperfusion. Shock. 1999;11:391 –395.
   Google Scholar
• Colletti LM, Burtch GD, Remick DG, Kunkel SL, Strieter RM, Guice KS, Oldham KT, Campbell DA. The produc- tion of tumor necrosis factor alpha and the develop- ment of a pulmonary capillary injury following hepatic is- chemia/reperfusion. Transplantation. 1990;49:268 –272.
   Google Scholar
• McCarron RM, Wang L, Stanimirovic DB, Spatz M. En- dothelin induction of adhesion molecule expression on human brain microvascular endothelial cells. Neurosci Lett. 1993;156:31 –34.
   Google Scholar
• Zhang JX, Pegoli W, Clemens MG. Endothelin- 1 induces direct constriction of hepatic sinusoids. Am J Physiol. 1994;266:G624–G632.
   Google Scholar
• Bauer M, Zhang JX, Bauer I, Clemens MG. ET-1 in- duced alterations of hepatic microcirculation: sinu- soidal and extrasinusoidal sites of action. Am J Physiol. 1994;267:G143–G149.
   Google Scholar
• Tanikawa K. Hepatic sinusoidal cells and sinusoidal circu- lation. J Gastroenterol Hepatol. 1995;10:S8–S11.
   Google Scholar
• Kawada N, Tran-Thi TA, Klein H, Decker K. The contrac- tion of hepatic stellate (Ito) cells stimulated with vasoac- tive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. Eur J Biochem. 1993;213:815 –823.
   Google Scholar
• Pinzani M, Failli P, Ruocco C, Casini A, Milani S, Baldi E, Giotti A, Gentilini P. Fat-storing cells as liver-specifc peri- cytes. Spatial dynamics of agonist-stimulated intracellular calcium transients. J Clin Invest. 1992;90:642 –646.
   Google Scholar
• Sakamot o M. Effect of endothelin- 1 on the contrac- tion of Ito cells (fat-storing cells). Acta Hepatol Jpn. 1991;32:1027 –1033.
   Google Scholar
• Marzi I, Knee J, Menger MD, Harbauer G, Buhren V. Hepatic microcirculatory disturbances due to portal vein clamping in the orthotopic rat liver transplantation model. Transplantation. 1991;52,3:432 –436.
   Google Scholar
• Kurihara T, Akimoto M, Kurokawa K, Ishiguro H, Niimi A, Maeda A, Sigemoto M, Yamashita K, Yokoyama I, Hirayama Y, Ihara M, Yano M. Relationship between en- dothelin and thromboxane A2 in rat liver microcirculation.
   Google Scholar
• Sirvio¨ML, Saijonmaa O, Metsa¨ rinne K, Fyhrquoist F.Life Sci. 1992;51:281 –285. Degradation of endothelin- 1 by extracts of rat lung, kid- ney, and liver. Regul Peptides. 1995;55:219 –225.
   Google Scholar
• Edano T, Arai K, Ohshima T. Purifcation and characteri- zation of endothelin-1 degradation activity from porcine kidney. Biol Pharmacol Bull. 1994;17:379 –382.
   Google Scholar
• Janas J, Sitkiewic D, Pulawska MF, Warnawin K, Janas RM. Characterization of a novel, high-molecular weight, acid, endothelin-1-inactivating metalloendotpeptidas e from the rat kidney. J Hypertens. 1994;12:1155 –1162.
   Google Scholar
• Zhang B, Calmus Y, Wen L, Sogni P, Lotersztajn S, Houssin D, Weill B. Endothelin- 1 induces liver vasocon- striction through both ETA and ETB receptors. J Hepatol. 1996;26:1104 –1110.
   Google Scholar
• Scommotau S, Uhlmann D, Spiegel HU. Con- trolled selective vasoregulation of postischemic liver microcirculation—A therapeutic approach. Eur J Surg. 1997;29(Supp l 1):7.
   Google Scholar
• Spiegel HU, Scommotau S, Uhlmann D, Giersch B. Effect of endothelin receptor antagonist bosentan on postischemic liver microcirculation. Zentralbl Chir. 1996;121:788 –793.
   Google Scholar
• Ko¨ ppel TA, Kraus T, Thies JC, Gebhard MM, Otto G, Post S. Postischemic improvement of hepatic microhemody- namics by a mixed ETA-, ETB-receptor antagonist (Ro-47- 0203). Transplant Proc. 1997;29:1365 –1366.
   Google Scholar
• Herrero I, Torras J, Riera M, Condom E, Coll O, Cruzado JM, Hueso M, Bover J, Lloberas N, Alsina J, Grinyo JM. Prevention of cold ischemia-reperfusion injury by an endothelin receptor antagonist in experimental renal transplantation. Nephrol Dial Transplant. 1999;14:872 – 880.
   Google Scholar
• Stammberger U, Carboni GL, Hillinger S, Schneiter D, Weder W, Schmid RA. Combined treatment with endothelin- and PAF-antagonists reduces posttransplant lung ischemia/reperfusion injury. J Heart Lung Transplant. 1999;18:862 –868.
   Google Scholar
• Simonson MS, Herman WH, Robinson A, Schulak J, Hricik DE. Inhibition of endothelin-converting enzyme attenuates transplant vasculopathy and rejection in rat cardiac allografts. Transplantation. 1999;67:1542 – 1547.
   Google Scholar
• Fukunaga K, Takada Y, Taniguchi H, Mei G, Seino KI, Yuzawa K, Otsuka M, Todoroki T, Goto K, Fukao K. En- dothelin antagonist treatment for successful liver trans- plantation from non-heart-beating donors. Transplanta- tion. 1999;67:328 –332.
   Google Scholar
• Hvaal K, Mathisen SR, Svindland A, Nordsletten L, Skjedal S. Protective effect of the endothelin antagonist bosen- tan against ischemic skeletal muscle necrosis. Acta Orthop Scand. 1999;70:293–297.
   PubMed Web of Science ®Google Scholar
• Menger MD, Pelikan S, Steiner D, Messmer K. Mi- crovascular ischemia-reperfusion injury in striated mus- cle: Signifcance of “relow paradox.” Am J Physiol. 1992;263:H1901–H1906.
   Google Scholar
• Boros M, Massberg S, Baranyi L, Okada H, Messmer K. Endothelin 1 induces leukocyte adhesion in submu- cosal venules of the rat small intestine. Gastroenterology 1998;114:103 –114.
   Google Scholar
• Li H, Elton TS, Chen YF, Oparil S. Increased endothelin receptor gene expression in hypoxic rat lung. Am J Physiol. 1994;266:L553–L560.
   Google Scholar
• Elton ST, Oparil S, Taylor GR, Hicks PH, Yang RH, Jin H, Chen YF. Normobaric hypoxia stimulates endothelin-1 gene expression in the rat. Am J Physiol. 1992;263:R1260–R1264.
   Google Scholar
• Ritthaler T, Go¨ pfert T, Firth JD, Ratcliffe TJ, Kramer BK, Kurtz A. Inluence of hypoxia on hepatic and renal en- dothelin gene expression. P/u¨gers Arch Eur J Physiol. 1996;431:587 –593.
   Google Scholar
• Gandhi CR, Harvey SAK, Olson MS. Hepatic effects of en- dothelin: Metabolism of [125I]endothelin-1 by liver-derived cells. Arch Biochem Biophys. 1993;305:38 –46.
   Google Scholar
• Marotto ME, Thurman RG, Lemasters JJ. Early midzonal death during low-low hypoxia in the isolated perfused rat liver: Protection by allupurinol. Hepatology. 1988;8:585– 590.
   Google Scholar